
Nate Silver @NateSilver538
Why did the FDA recommend the pause anyway? Because of a combination of institutional culture, cognitive biases, and bureaucratic imperatives incentives, they greatly overweight the importance of rare adverse effects relative to people dying from COVID. — PolitiTweet.org